State of the science: Use of biomarkers and imaging in diagnosis and management of alzheimer disease

Journal of Neuroscience Nursing

Volumn 45, Issue 2, 2013, Pages 63-70

  Fraller, Deirdre Brett ^a  

^a NONE

Author keywords

Alzheimer; Biomarkers; CSF; MRI; PET

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; GERIATRIC NURSING; HUMAN; METABOLISM; NURSING; PATHOLOGY; PRACTICE GUIDELINE; SCINTISCANNING; STANDARD;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; GERIATRIC NURSING; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84877874626     PISSN: 08880395     EISSN: 19452810     Source Type: Journal    
DOI: 10.1097/JNN.0b013e3182829024     Document Type: Article

References (29)

1. Alzheimer's Association, Thies, W., & Bleiler, L. (2011). 2011 alzheimer's disease facts and figures. Alzheimer' s and Dementia: Journal of the Alzheimer's Association, 7(2), 208-244. doi:10.1016/j.jalz.2011.02.004
2. Ballard C. (2011). Alzheimer's disease. Lancet (North American Edition), 377(9770), 1019.
3. Bekris, L. M., Yu, C. E., Bird, T. D., & Tsuang, D. W. (2010). Genetics of alzheimer disease. Journal of Geriatric Psychiatry and Neurology, 23(4), 213-227. doi:10.1177/089198871 0383571
4. Burns, A., & Iliffe, S. (2009). Alzheimer's disease. British Medical Journal, 338, 467-471.
5. Buschert, V., Bokde, A., & Hampel, H. (2010). Cognitive intervention in alzheimer disease. Nature Reviews Neurology, 6, 508-517.
6. Castellani, R. J., Lee, H. G., Siedlak, S. L., Nunomura, A., Hayashi, T., Nakamura, M., I Smith, M. A. (2009). Reexamining alzheimer's disease: Evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. Journal of Alzheimer'sDisease, 18(2), 447-452. doi:10.3233/ JAD-2009-1151
7. Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010). Alzheimer disease. Disease-a-Month, 56(9), 484-546. doi:10.1016/j.disamonth.2010.06.001
8. Fagan, A. M., & Holtzman, D. M. (2010). Cerebrospinal fluid biomarkers of alzheimer' s disease. Biomarkers in Medicine, 4(1), 51-63. doi:10.2217/BMM.09.83
9. Frisoni, G. B., Fox, N. C., Jack, C. R. Jr., Scheltens, P., & Thompson, P. M. (2010). The clinical use of structural MRI in alzheimer disease. Nature Reviews: Neurology, 6(2), 67-77. doi:10.1038/nrneurol.2009.215
10. Hampel, H., Burger, K., Teipel, S. J., Bokde, A. L., Zetterberg, H., & Blennow, K. (2008). Core candidate neurochemical and imaging biomarkers of alzheimer's disease. Alzheimer's and Dementia: Journal of the Alzheimer's Association, 4(1), 38-48. doi:10.1016/j.jalz.2007.08.006
11. Hazewinkel, M., & Barkhof, F. (2011). Imaging alzheimer in 2011. Neuroradiology, 53(Suppl 1), S145YS147. doi:10.1007/ s00234-011-0931-6
12. Kadir, A., & Nordberg, A. (2010). Target-specific PET probes for neurodegenerative disorders related to dementia. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 51(9), 1418-1430. doi:10.2967/jnumed .110.077164
13. Leifer B. P. (2009). Alzheimer's disease: Seeing the signs early. Journal of the American Academy of Nurse Practitioners, 21(11), 588.
14. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., I Phelps, C. H. (2011). The diagnosis of dementia due to alzheimer's disease: Recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease. Alzheimer's and Dementia: Journal of the Alzheimer's Association, 7(3), 263-269. doi:10.1016/j.jalz.2011.03.005
15. Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., I de Leon, M. J. (2008). Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, alzheimer' s disease, and other dementias. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 49(3), 390-398. doi:10.2967/ jnumed.107.045385
16. National Institutes of Health. (2010). NIH consensus development conference statement on preventing alzheimer's diseas e and cognitive decline. NIH Consensus and State-of-the-Science Statements, 27(4), 1-30.
17. Osborn, G. G., & Saunders, A. V. (2010). Current treatments for patients with alzheimer disease. Journal of the American Osteopathic Association, 110(9 Suppl 8), S16-S26.
18. Querforth, H., & LaFerla, F. (2010). Mechanisms of disease: Alzheimer's disease. New England Journal of Medicine, 362(4), 329-344.
19. Rowe, C. C., & Villemagne, V. L. (2011). Brain amyloid imaging. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 52(11), 1733-1740. doi:10 .2967/jnumed.110.076315
20. Savica, R., & Petersen, R. C. (2011). Prevention of dementia. Psychiatric Clinics of North America, 34(1), 127-145. doi:10.1016/j.psc.2010.11. 006
21. Strassnig, M., & Ganguli, M. (2005). About a peculiar disease of the cerebral cortex: Alzheimer's original case revisited. Psychiatry (Edgmont (Pa.: Township)), 2(9), 30-33.
22. Struble, R. G., Ala, T., Patrylo, P. R., Brewer, G. J., & Yan, X. X. (2010). Is brain amyloid production a cause or a result of dementia of the alzheimer 's type? Journal of Alzheimer's Disease, 22(2), 393-399. doi:10.3233/JAD-2010-100846
23. Swerdlow, R. H. (2011). Alzheimer's disease pathologic cascades: Who comes first, what drives w hat. Neurotoxicity Research, 22(3), 182-194. doi:10.1007/s12640-011-9272-9
24. The Alzheimer's Association. (2010). Changing the trajectory of alzheimer's disease: A national imperative. Washington, DC:
25. Author. Weiner, M., Aisen, P., Jack, c., Jagust, W., Trojanowski, J., Shaw, L., I the Alzheimer's Disease Neuroimaging Initiative. (2010). The alzheimer's disease neuroimaging initiative: Progress report and future plans. Alzheimer's and Dementia: Journal of the Alzheimer's Association, 6, 202-211.
26. Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., I Alzheimer's Disease Neuroimaging Initiative. (2011). The alzheimer's disea se neuroimaging initiative: A review of papers published since its inception. Alzheimer's and Dementia: Journal of the Alzheimer's Association, 8(Suppl 1), S1YS68. doi:10 .1016/j.jalz.2011.09.172
27. Zetterberg, H. (2008). Is plasma amyloid-beta a reliable biomarker for alzheimer's disease? Recent Patents on CNS Drug Discovery, 3(2), 109-111.
28. Zetterberg, H., Blennow, K., & Hanse, E. (2010). Amyloid beta and APP as biomarkers for alzheimer's disease. Experimental Gerontology, 45(1), 23 -29. doi:10.1016/j.exger.2009 .08.002
29. Zhang, D., Wang, Y., Zhou, L., Yuan, H., Shen, D., & Alzheimer's Disease Neuroimaging Initiative. (2011). Multimodal classification of alzheimer's disease and mild cognitive impairment. NeuroImage, 55(3), 856-867. doi:10.1016/ j.neuroimage.2011.01.008